Hepatocyte growth factor may act as an early therapeutic predictor in pneumonia

Scandinavian Journal of Infectious Diseases

Volumn 34, Issue 7, 2002, Pages 500-504

  Nayeri, Fariba ^a   Brudin, Lars ^a   Darelid, Johan ^a   Nilsson, Ingela ^a   Fryden, Aril ^a   Söderström, Claes ^a   Forsberg, Pia ^a  

^a LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; C REACTIVE PROTEIN; CYTOKINE; PENICILLIN G; SCATTER FACTOR; ANTIINFECTIVE AGENT;

ADULT; AGED; ARTICLE; CHLAMYDOPHILA PNEUMONIAE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; DRUG EFFICACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; MYCOPLASMA PNEUMONIAE; PNEUMONIA; PREDICTION; PROSPECTIVE STUDY; STREPTOCOCCUS PNEUMONIAE; TISSUE REGENERATION; TREATMENT OUTCOME; BLOOD; CASE CONTROL STUDY; CLINICAL TRIAL; ENZYME LINKED IMMUNOSORBENT ASSAY; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; PREDICTION AND FORECASTING; PROGNOSIS;

ADULT; AGED; AGED, 80 AND OVER; ANTIBIOTICS; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATOCYTE GROWTH FACTOR; HUMAN; MALE; MIDDLE AGE; PNEUMONIA; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SUPPORT, NON-U.S. GOV'T; ANTI-BACTERIAL AGENTS; HUMANS; MIDDLE AGED;

EID: 0035990756     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365540110080890     Document Type: Article

References (27)

1. Purification and partial characterization of hepatocyte growth factor from plasma of a patient with fulminate hepatic failure
2. Activation of hepatocyte growth factor by proteolytic conversion of a single chain form to a heterodimer
3. Hepatocyte growth factor: Molecular structure and implications for a central role in liver regeneration
4. Scatter factor is a fibroblast-derived modulator of epithelial cell mobility
5. Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth
6. Identification of a fibroblast-derived epithelial morphogen as hepatocyte growth factor
7. The presence of hepatocyte growth factor in the developing rat
8. The pharmacokinetics, tissue localization, and metabolic processing of recombinant human hepatocyte growth factor after intravenous administration in rats
9. Emerging multipotent aspects of hepatocyte growth factor
10. Marked induction of hepatocyte growth factor mRNA in intact kidney and spleen in response to injury of distant organs
11. Keratinocyte growth factor and hepatocyte growth factor/scatter factor are heparin-binding growth factors for alveolar type II cells in fibroblast-conditioned medium
12. Hepatocyte growth factor may act as a pulmotrophic factor on lung regeneration after acute lung injury
13. High serum hepatocyte growth factor levels in the acute stage of community-acquired infectious diseases
14. Plasma hepatocyte growth factor levels are increased in systemic inflammatory response syndrome
15. Elevated serum hepatocyte growth factor/scatter factor levels in inflammatory lung disease
16. Hepatocyte growth factor levels in cerebrospinal fluid: A comparison between acute bacterial and nonbacterial meningitis
17. Identification and characterization of "injurin" an inducer of expression of the gene for hepatocyte growth factor
18. Hepatocyte growth factor in assessment of acute pancreatitis: Comparison with C-reactive protein and interleukin-6
19. Hepatocyte growth factor (HGF) in patients with pneumonia: A comparison between survivors and non-survivors
20. The C-reactive protein
21. The value of C-reactive protein as a marker of bacterial infection in patients with septicaemia/endocarditis and influenza
22. C-reactive protein concentration as a guide to antibiotic therapy in acute leukaemia
23. C-reactive protein
24. A detailed analysis of changes in serum C-reactive protein levels in neonates treated for bacterial infection
25. Decrease in the hepatic clearance of hepatocyte growth factor in carbon tetrachloride-intoxicated rats
26. Prediction of outcome in fulminant hepatic failure by serum human hepatocyte growth factor
27. Importance of the liver in plasma clearance of hepatocyte growth factor in rats